Raluca Trifănescu

739 total citations
31 papers, 465 citations indexed

About

Raluca Trifănescu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Raluca Trifănescu has authored 31 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 6 papers in Oncology. Recurrent topics in Raluca Trifănescu's work include Pituitary Gland Disorders and Treatments (10 papers), Adrenal and Paraganglionic Tumors (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Raluca Trifănescu is often cited by papers focused on Pituitary Gland Disorders and Treatments (10 papers), Adrenal and Paraganglionic Tumors (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Raluca Trifănescu collaborates with scholars based in Romania, United Kingdom and United States. Raluca Trifănescu's co-authors include Niki Karavitaki, Olaf Ansorge, John Wass, Ashley Grossman, Helen Turner, Gaya Thanabalasingham, Metaxia Tampourlou, Alessandro Paluzzi, Shahzada Ahmed and Cătălina Poiană and has published in prestigious journals such as Clinical Endocrinology, European Journal of Endocrinology and Cancers.

In The Last Decade

Raluca Trifănescu

28 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raluca Trifănescu Romania 9 364 263 70 57 37 31 465
Marcos Manavela Argentina 12 531 1.5× 261 1.0× 70 1.0× 61 1.1× 68 1.8× 26 588
Karina Danilowicz Argentina 12 448 1.2× 239 0.9× 90 1.3× 86 1.5× 57 1.5× 43 608
Georgiana Dobri United States 12 304 0.8× 152 0.6× 148 2.1× 112 2.0× 16 0.4× 27 377
E. Sonnet France 13 298 0.8× 129 0.5× 55 0.8× 35 0.6× 96 2.6× 39 412
Roman Rotermund Germany 13 284 0.8× 159 0.6× 101 1.4× 113 2.0× 27 0.7× 33 394
Miguel Paja Spain 9 234 0.6× 139 0.5× 28 0.4× 47 0.8× 16 0.4× 21 309
Marie Laure Raffin‐Sanson France 8 228 0.6× 171 0.7× 84 1.2× 29 0.5× 118 3.2× 11 422
R V Randall United States 8 329 0.9× 166 0.6× 97 1.4× 101 1.8× 57 1.5× 12 404
Vincent Amodru France 9 240 0.7× 158 0.6× 70 1.0× 62 1.1× 20 0.5× 22 320
Joaquín Sola Spain 11 98 0.3× 192 0.7× 66 0.9× 35 0.6× 48 1.3× 18 328

Countries citing papers authored by Raluca Trifănescu

Since Specialization
Citations

This map shows the geographic impact of Raluca Trifănescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raluca Trifănescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raluca Trifănescu more than expected).

Fields of papers citing papers by Raluca Trifănescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raluca Trifănescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raluca Trifănescu. The network helps show where Raluca Trifănescu may publish in the future.

Co-authorship network of co-authors of Raluca Trifănescu

This figure shows the co-authorship network connecting the top 25 collaborators of Raluca Trifănescu. A scholar is included among the top collaborators of Raluca Trifănescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raluca Trifănescu. Raluca Trifănescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niculescu, D, et al.. (2024). Comparative mortality in pituitary adenomas subtypes: a tertiary referral center study. Endocrine. 87(2). 782–787.
2.
Găloiu, Simona, et al.. (2024). High mortality risk among women with acromegaly still persists. Frontiers in Endocrinology. 15. 1348972–1348972. 7 indexed citations
6.
Trifănescu, Raluca, et al.. (2023). The Female Reproductive Tract Microbiome and Cancerogenesis: A Review Story of Bacteria, Hormones, and Disease. Diagnostics. 13(5). 877–877. 12 indexed citations
7.
Galeş, Laurenţia, Natalia Motaș, Raluca Trifănescu, et al.. (2022). Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?. Medicina. 59(1). 50–50. 3 indexed citations
8.
Cîmpean, Anca Maria, Raluca Amalia Ceauşu, Cristina Căpățînă, et al.. (2021). Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas and Correlation With Preoperative Laboratory Findings. Anticancer Research. 41(5). 2669–2680. 3 indexed citations
9.
Căpățînă, Cristina, Simona Găloiu, D Niculescu, et al.. (2020). Improvement of acromegaly control with multimodal therapy in Romania. Endokrynologia Polska. 71(3). 235–239. 5 indexed citations
10.
Tampourlou, Metaxia, Raluca Trifănescu, Alessandro Paluzzi, Shahzada Ahmed, & Niki Karavitaki. (2016). THERAPY OF ENDOCRINE DISEASE: Surgery in microprolactinomas: effectiveness and risks based on contemporary literature. European Journal of Endocrinology. 175(3). R89–R96. 59 indexed citations
11.
Niculescu, D, Cristina Căpățînă, Simona Găloiu, et al.. (2015). Acromegaly treatment in Romania. How close are we to disease control?. Endokrynologia Polska. 68(5). 519–523. 8 indexed citations
12.
Carşote, Mara, et al.. (2013). Antithyroid drugs induced agranulocytosis and multiple myeloma: case report and general considerations.. PubMed. 6(3). 327–31. 3 indexed citations
13.
Trifănescu, Raluca, et al.. (2013). Screening for secondary endocrine hypertension in young patients.. PubMed. 8(2). 108–15. 14 indexed citations
14.
Poiană, Cătălina, et al.. (2013). The dedifferentiation of neuroendocrine tumor metastases: myth or reality?. PubMed. 54(1). 201–3. 13 indexed citations
15.
Poiană, Cătălina, et al.. (2013). The poor prognosis factors in G2 neuroendocrine tumor.. PubMed. 54(3 Suppl). 717–20. 13 indexed citations
16.
Trifănescu, Raluca, Olaf Ansorge, John Wass, Ashley Grossman, & Niki Karavitaki. (2011). Rathke’s cleft cysts. Clinical Endocrinology. 76(2). 151–160. 105 indexed citations
17.
Trifănescu, Raluca, Vasilis Stavrinides, Puneet Plaha, et al.. (2011). Outcome in surgically treated Rathke's cleft cysts: long-term monitoring needed. European Journal of Endocrinology. 165(1). 33–37. 33 indexed citations
18.
Karavitaki, Niki, Gaya Thanabalasingham, Raluca Trifănescu, et al.. (2006). Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary macroadenoma. Clinical Endocrinology. 65(4). 524–529. 139 indexed citations
19.
Trifănescu, Raluca, Niki Karavitaki, Mihail Coculescu, Helen Turner, & John Wass. (2005). What is the final outcome in patients with macroprolactinoma resistant to dopamine agonists. 9. 1 indexed citations
20.
Trifănescu, Raluca, et al.. (2004). Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.. PubMed. 42(3). 595–605. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026